FIELD: biotechnology.
SUBSTANCE: invention relates to an antibody or its antigen-binding fragment that binds to 4-1BB. Also the following is disclosed: the use of the above antibody or an antigen binding fragment thereof to produce a bispecific antibody.
EFFECT: invention is effective for the treatment of cancer.
15 cl, 83 dwg, 49 tbl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBODIES AGAINST CD40 AND THEIR USE | 2018 |
|
RU2796413C2 |
ANTIBODIES AGAINST OX40 AND THEIR USE | 2017 |
|
RU2783314C2 |
ANTIBODY FOR SPECIFIC BINDING WITH INTERLEUKIN 4 RECEPTOR | 2017 |
|
RU2774446C2 |
ANTIBODIES AGAINST CTLA4 AND THEIR USE | 2017 |
|
RU2779312C2 |
ANTIBODY AGAINST CLAUDIN 18A2 AND ITS USE | 2020 |
|
RU2811431C2 |
MANAGEMENT, NAVIGATION AND CONTROL PROTEINS AND METHOD OF THEIR OBTAINING AND USE | 2019 |
|
RU2811457C2 |
MULTI-SPECIFIC ANTIBODIES AND METHODS OF THEIR PRODUCTION AND USE | 2018 |
|
RU2811477C2 |
ANTIBODIES BINDING TO HUMAN CANNABINOID RECEPTOR 1 (CB1) | 2015 |
|
RU2730674C2 |
BISPECIFIC FUSION PROTEIN AND ITS USE | 2021 |
|
RU2801528C2 |
TRISPECIFIC BINDING PROTEINS, RELATED METHODS AND VERSIONS OF USE THEREOF | 2020 |
|
RU2822200C2 |
Authors
Dates
2024-01-25—Published
2019-09-11—Filed